Abstract:Due to the poor permeability across Gram-negative bacterial membranes and the troublesome bacterial efflux mechanism, only a few GyrB/ParE inhibitors with potent activity against Gram-negative pathogens have been reported. Among them, pyrimido[4,5-b]indole derivatives represented by GP-1 demonstrated excellent broad-spectrum antibacterial activity against both Gram-positive and Gram-negative bacteria but were limited by hERG inhibition and poor pharmacokinetics profile. To improve their drug-like properties, we designed a series of novel pyrimido[4,5-b]indole derivatives based on the tricyclic scaffold of GP-1 and the C-7 moiety of acorafloxacin. These efforts have culminated in the discovery of a promising compound 18r with reduced hERG liability and an improved PK profile. Compound 18r exhibited superior broad-spectrum in vitro antibacterial activity compared to GP-1, including a variety of clinical multidrug G– pathogens, especially Acinetobacter baumannii, and the in vivo efficacy was also demonstrated in a neutropenic mouse thigh model of infection with multidrug-resistant A. baumannii.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00621?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00621</a>.More MIC data and details of tested compounds for <a class="ref showTableEvent internalNav" href="#tbl1">Tables </a><a class="ref showTableEvent internalNav" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" href="#tbl4">4</a>; more MIC data and details of tested compounds for <a class="ref showTableEvent internalNav" href="#tbl5">Table </a><a class="ref showTableEvent internalNav" href="#tbl5">5</a>; metabolite identification of compound 18k in rat liver microsomes; proposed metabolic pathways of compound 18k; preparation and characterization data of all intermediates; NMR spectra and HRMS data of final compounds; and HPLC traces for lead compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00621/suppl_file/jm1c00621_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00621/suppl_file/jm1c00621_si_002.csv">CSV</a>)This article has not yet been cited by other publications.

Design, synthesis and evaluation of novel LpxC inhibitors containing a hydrazone moiety as Gram-negative antibacterial agents

Design,synthesis and Biological Evaluation of LpxC Inhibitors with Novel Hydrophilic Terminus

Design, Synthesis and Structure-Activity Relationship Evaluation of Novel LpxC Inhibitors As Gram-negative Antibacterial Agents

Small Molecule LpxC Inhibitors Against Gram-Negative Bacteria: Advances and Future Perspectives

Synthesis and Biological Evaluation of 3-(Pyridine-3-yl)-2-oxazolidinone Derivatives As Antibacterial Agents.

Design, synthesis, and bioactivity investigation of novel cyclic lipopeptide antibiotics targeting top-priority multidrug-resistant gram-negative bacteria

Optimization and Antibacterial Evaluation of Novel 3-(5-Fluoropyridine-3-yl)-2-oxazolidinone Derivatives Containing a Pyrimidine Substituted Piperazine

Preclinical safety and efficacy characterization of an LpxC inhibitor against Gram-negative pathogens

Exploration of the structure-activity relationship and druggability of novel oxazolidinone-based compounds as Gram-negative antibacterial agents.

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Design, Synthesis, and Biological Evaluation of Novel Pyrimido[4,5- b ]indole Derivatives Against Gram-Negative Multidrug-Resistant Pathogens

TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae

Design, Synthesis, and Biological Evaluation of Novel Arylomycins against Multidrug-Resistant Gram-Negative Bacteria

Design, synthesis, and in vitro biological evaluation of meta -sulfonamidobenzamide-based antibacterial LpxH inhibitors

Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of <i>Pseudomonas aeruginosa</i> PAO1

UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) inhibitors: a new class of antibacterial agents.

Discovery of novel phenylhydrazone-based oxindole-thiolazoles as potent antibacterial agents toward Pseudomonas aeruginosa

Design, Synthesis and Antibacterial Activity of Novel Colistin Derivatives with Thioether Bond-Mediated Cyclic Scaffold.

Molecular Design and the Optimum Synthetic Route of the Compounds with Multi-Pyrazole and Its Derivatives and the Potential Application in Antibacterial Agents

Design, Synthesis and Antimicrobial Evaluation of Novel Benzoxazole Derivatives.

Synthesis and Antimicrobial Evaluation of (Z)-5-((3-phenyl-1h-pyrazol-4- Yl)methylene)-2-thioxothiazolidin-4-one Derivatives